Viking Therapeutics, Inc.VKTXNASDAQ
LOADING
|||
Switch Symbol:
EBITDA Over Time
Trending lower, below historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-150.57M
↓ 229% below average
Average (9y)
$-45.72M
Historical baseline
Range
High:$4.66M
Low:$-150.57M
CAGR
+23.6%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-150.57M | -49.8% |
| 2023 | $-100.53M | -43.5% |
| 2022 | $-70.06M | -26.5% |
| 2021 | $-55.39M | -41.6% |
| 2020 | $-39.11M | -54.1% |
| 2019 | $-25.37M | -644.5% |
| 2018 | $4.66M | +952.2% |
| 2017 | $442882.00 | -61.4% |
| 2016 | $1.15M | +105.1% |
| 2015 | $-22.39M | - |